Nanowear is a wearable technology platform for medical diagnostics and chronic disease management based on the Company’s proprietary invention of textile-based nanosensors. Nanowear’s flagship product, SimpleSense, is the first-of-its-kind, non-invasive wearable garment for disease management of Congestive Heart Failure. SimpleSense uses these cloth-based, FDA-cleared (Class II) nanosensors to capture multi-channel ECG, Heart-rate variability, Respiratory Rate, Impedance Cardiography (stroke volume / cardiac output), thoracic impedance, actigraphy and cardio-phonography (S3 and S4 detection). Nanowear’s platform algorithmically scores the combination of these metrics for a unique, daily SimpleSense score alerting physicians and caretakers of advanced decompensating heart failure, reducing hospital admissions due to heart failure events. Nanowear’s proprietary sensor technology can also be licensed as a sensor consumable for already-built healthcare products in need of medical-grade sensor technology where exponentially higher signal-to-noise- ratios show capture is unaffected by body hair, moisture, sweat, and motion artifact is significantly reduced.
State of Ownership